Results
1508
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,508 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CRDO | US$28.51 | 17.5% | 89.7% | US$4.7b | US$35.33 | PS21.8x | E94.1% | n/a | Semiconductors | ||
EH | US$12.15 | 4.1% | -29.4% | US$768.9m | US$24.76 | PS21.9x | E81.5% | n/a | Capital Goods | ||
A067310 | ₩11,450.00 | 2.0% | -52.9% | ₩690.3b | ₩21,898.55 | PB2.4x | E100.3% | 0.4% | Semiconductors | ||
A178320 | ₩25,600.00 | 5.6% | 66.9% | ₩1.4t | ₩39,333.33 | PE27.8x | E52.1% | 0% | Tech | ||
AESI | US$20.64 | 3.8% | -10.5% | US$2.3b | US$26.00 | PE15.5x | E42.1% | 4.5% | Energy | ||
LAVV3 | R$8.74 | 3.3% | 10.1% | R$1.7b | R$12.98 | PE6.3x | E20.6% | 3.3% | Real Estate Management and Development | ||
A179900 | ₩20,750.00 | -4.2% | -32.2% | ₩328.3b | ₩60,000.00 | PS16.4x | E134.6% | 0% | Tech | ||
688408 | CN¥65.70 | 6.7% | 44.2% | CN¥13.2b | CN¥69.26 | PE27.6x | E29.9% | 0.9% | Capital Goods | ||
4480 | JP¥3,185.00 | -7.4% | -36.8% | JP¥103.5b | JP¥5,400.00 | PE38.5x | E30.4% | n/a | Healthcare | ||
A137400 | ₩49,150.00 | 1.1% | -29.4% | ₩1.1t | ₩85,350.00 | PE12.4x | E35.6% | 0% | Capital Goods | ||
YGG | ฿0.99 | -2.0% | -86.5% | ฿596.0m | ฿10.75 | PS2.1x | E85.5% | 27.1% | Media | ||
6181 | HK$113.10 | 23.0% | n/a | HK$19.0b | HK$128.58 | PE21.5x | E34.7% | n/a | Consumer Durables | ||
PLT | AU$0.70 | 0.7% | 86.7% | AU$122.7m | AU$1.30 | PS1.7x | E106.4% | n/a | Diversified Financials | ||
505283 | ₹1,327.00 | 4.3% | 124.9% | ₹85.7b | ₹1,706.50 | PE60.5x | E30.1% | 0.5% | Capital Goods | ||
KEBNI B | SEK 1.20 | -1.5% | 1.0% | SEK 325.4m | SEK 2.20 | PS2.8x | E86.1% | n/a | Tech | ||
ADOC | €5.57 | -4.3% | -38.5% | €83.8m | €6.30 | PS13.8x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
CUV | AU$15.07 | 3.6% | -6.7% | AU$754.5m | AU$29.17 | PE21.2x | E27.4% | 0.3% | Pharmaceuticals & Biotech | ||
AV1 | AU$0.059 | -1.7% | 43.9% | AU$46.5m | n/a | PS11.2x | E144.2% | n/a | Software | ||
ACI | ₹699.60 | -0.2% | 15.7% | ₹86.1b | ₹878.71 | PE32x | E33.7% | 0.4% | Materials | ||
ATAT | US$19.65 | 3.4% | 0.6% | US$2.7b | US$26.93 | PE18.4x | E23.2% | 2.3% | Consumer Services | ||
AAUC | CA$3.39 | 17.7% | -32.9% | CA$873.1m | CA$8.43 | PB2.1x | E73.5% | n/a | Materials | ||
HIMS | US$16.57 | 18.6% | 161.4% | US$3.6b | US$21.93 | PE198.1x | E40.7% | n/a | Healthcare | ||
A039200 | ₩35,700.00 | 3.0% | 26.6% | ₩1.4t | ₩56,000.00 | PS295.2x | E122.0% | n/a | Pharmaceuticals & Biotech | ||
603203 | CN¥17.58 | -3.6% | -30.0% | CN¥4.4b | n/a | PE21.8x | E33.1% | 3.4% | Capital Goods |